The highs and lows of venetoclax with hypomethylating agents for refractory AML

被引：0
|
作者：
Brunner, Andrew M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Zero Emerson Pl,Suite 118, Boston, MA 02114 USA
来源：
LEUKEMIA RESEARCH | 2020年 / 91卷
关键词：
Acute myeloid leukemia; Venetoclax; Azacitidine; Decitabine;
D O I：
10.1016/j.leukres.2020.106320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Highs and lows
    Coghlan, A
    NEW SCIENTIST, 1997, 156 (2105) : 36 - 39
  • [22] Molecular Ontogeny in AML Is Both Prognostic and Predictive in Patients Treated with Hypomethylating Agents Plus Venetoclax
    Shimony, Shai
    Garcia, Jacqueline S.
    Keating, Julia
    Chen, Evan C.
    Luskin, Marlise R.
    Stahl, Maximilian
    Neuberg, Donna S.
    DeAngelo, Daniel J.
    Stone, Richard M.
    Lindsley, Coleman
    BLOOD, 2023, 142
  • [23] Highs and lows
    Strunk, Petra
    ZKG INTERNATIONAL, 2021, 74 (08): : 1 - 1
  • [24] Highs and Lows
    Benzel, Ed
    WORLD NEUROSURGERY, 2022, 164 : XXIII - XXIII
  • [25] Highs and lows
    Hutchinson, E
    NATURE REVIEWS CANCER, 2003, 3 (01) : 8 - 8
  • [26] Highs and lows
    Carroll-Johnson, RM
    ONCOLOGY NURSING FORUM, 2005, 32 (04) : 715 - 715
  • [27] Highs and lows
    David Nichols
    Nature Chemistry, 2010, 2 (3) : 153 - 153
  • [28] Highs and lows
    Patterson, M
    NATURE REVIEWS GENETICS, 2000, 1 (02) : 83 - 83
  • [29] 'Highs and Lows'
    Malroux, C
    TRIQUARTERLY, 2001, (110-11): : 205 - 211
  • [30] Highs and lows
    Mark Patterson
    Nature Reviews Genetics, 2000, 1 : 83 - 83
12345